CD163

CD163

CD163 詳細

Molecule Name
Scavenger receptor cysteine-rich type 1 protein M130
分子の別称
CD163,M130
Drug Development Progress
治験薬の数1
市販薬剤の数1
研究&開発段階Approved
ターゲットの別称
CD163,M130,Scavenger receptor cysteine-rich type 1 protein M130,sCD163,CD163 Molecule,Hemoglobin Scavenger Receptor,CD163 Antigen,Macrophage-Associated Antigen,SCARI1,MM130
バックグランド
Scavenger receptor cysteine-rich type 1 protein M130 (CD163) is also known as hemoglobin scavenger receptor, which is a scavenger receptor for the hemoglobin-haptoglobin complex. CD163 has also been shown to mark cells of monocyte/macrophage lineage. A soluble form of the receptor exists in plasma, commonly denoted sCD163. sCD163 is generated by ectodomain shedding of the membrane bound receptor. sCD163 is upregulated in a large range of inflammatory diseases including liver cirrhosis, type 2 diabetes, macrophage activation syndrome, Gaucher's disease, sepsis, HIV infection, rheumatoid arthritis and Hodgkin Lymphoma.

CD163 製品リスト

No Data
You Have Viewed 0 Of 0 Results
  • 1

Can’t find what you need?

Submit your requirements and our technical
team will help.

治験薬に関する情報

英語名研究コード研究開発ステージ会社適応症臨床試験
OR-2805OR-2805Phase 2 ClinicalOncoResponse Inc
Carcinoma, Non-Small-Cell Lung; Leiomyosarcoma; Liposarcoma; Melanoma; Neoplasm Metastasis; Neoplasms; Solid tumours; Squamous Cell Carcinoma of Head and Neck
詳細

市販薬剤に関する情報

英語名研究コード研究開発ステージ会社オリジナル製品名最初に承認をした国最初の適応症最初に承認を受けた会社承認された日付適応症臨床試験
TetrachlorodecaoxideOXO-K993; WF-10; TCDOApprovedNuvox Pharma LLCOxoferin, Immunokine, WF10ThailandInflammation; Rhinitis, Allergicnull1997-01-01
Diabetic Foot; HIV Infections; Inflammation; Rhinitis, Allergic
詳細